Xin Zong | Animal Communication | Animal Science Innovator Award

Prof. Xin Zong | Animal Communication | Animal Science Innovator Award

Professor | Zhejiang University | China

Prof. Zong Xin is a highly impactful researcher in molecular biology, microbiome science, immunometabolism, and translational biomedicine, with a strong emphasis on host–microbe interactions, inflammatory signaling, and metabolic regulation. The scholar has produced 40 indexed publications, 2,247 citations, and an h-index of 28, reflecting sustained global influence and scientific consistency. Recent work spans obesity biology, reproductive microbiota, macrophage translational control, and inflammasome-mediated cell death, demonstrating broad interdisciplinary collaboration across 128 co-authors. This research contributes meaningfully to advances in precision health, metabolic disease intervention, and animal-biomedical sciences, with clear societal relevance for improving disease prevention, therapeutic innovation, and evidence-based bioscience applications.

Citation Metrics (Scopus)

2247
600
400
200
0

Citations

2247

Documents

40

h-index

28

Citations

Documents

h-index

View Scopus Profile
    View ORCID Profile
     View ResearchGate Profile

Featured Publications

Shu Yang | Immunology | Research Excellence Award

Dr. Shu Yang | Immunology | Research Excellence Award
Principal Investigator | Peking University Shenzhen Hospital | China

Dr. Yang Shu is a productive biomedical researcher specializing in molecular mechanisms underlying inflammatory disorders, renal injury, fibrosis, ferroptosis regulation, metabolic signaling pathways, and therapeutic bioactive compounds. With 56 publications, 1,149 citations, and an h-index of 21, the researcher demonstrates strong scholarly influence and sustained research visibility in translational disease biology. Collaborative engagement with a broad international co-author network (over 190 collaborators) reflects interdisciplinary integration across cell signaling, immunometabolism, and pharmacological intervention studies. Contributions advance mechanistic understanding of chronic disease progression and support development of targeted therapeutic strategies with potential clinical and public-health relevance, strengthening global biomedical innovation and evidence-based treatment perspectives .

Citation Metrics (Scopus)

1149
600
400
200
0

Citations

1149

Documents

56

h-index

21

Citations

Documents

h-index


View Scopus ProfileView ORCID Profile

Featured Publications


USP43-mediated HSPA8 deubiquitination alleviates diabetic kidney disease

– Biochemical and Biophysical Research Communications, 2025 | Citations: 2